Steven Cohen acquired 1.38 Million Immunovant shares worth $35.1 Million. That's 0.11% of their equity portfolio (250th largest holding). The first Immunovant trade was made in Q1 2020. Since then Steven Cohen bought shares six more times and sold shares on nine occasions. The investor's estimated purchase price is $50.9 Million, resulting in a loss of 31%.